“There is a clear need for an innovative device to help physicians more safely perform advanced IVC filter removal and I believe that the Philips excimer laser sheath may greatly enhance the options available to succeed in filter retrieval,” said Atul Gupta, MD, Interventional Radiologist and Chief Medical Officer, Image Guided Therapy, at Philips. “Breakthrough Device Designation reflects the potential impact that this technology could have on countless patients where this technology can be applied to safely retrieve filters by an expert physician, thereby reducing their risk of significant filter-related complications.” “Laser-assisted filter retrieval may be a critical tool for the safe retrieval of filters with extended implantation times,” said Kush R Desai, MD, FSIR, Associate Professor of Radiology, Surgery, and Medicine, and Director of Deep Venous Interventions at Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Physicians have very few tools to remove the filter when this happens and there are no FDA-approved devices for this type of advanced removal. Advanced retrieval tools and techniques are required if the IVC filter becomes embedded in the vasculature. The failure rate for IVC filter removal is high and limited options for removal exist if the filter has become difficult to remove. The FDA recommends that implanting physicians consider removing retrievable IVC filters as soon as they are no longer indicated. Other identified long-term risks associated with IVC filters include lower limb deep vein thrombosis and IVC occlusion. The filters can fracture and travel through the bloodstream to other parts of the body. Research has shown that IVC filters may have long-term complications. They are placed in the inferior vena cava to capture blood clots from moving to the heart or lungs. IVC filters are used to treat patients with venous thromboembolism, in which blood clots form in the deep veins of the leg, groin or arm and can travel through the circulatory system. The proposed device is intended for ablating tissue to remove an IVC filter when previous methods of removal have failed. Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the FDA has granted Breakthrough Device Designation (BDD) for a laser-assisted inferior vena cava (IVC) filter removal device.
0 kommentar(er)
